2 Generational Buy Opportunities for Your TFSA in 2022

TFSA stocks like WELL Health Technologies (TSX:WELL) have been beaten down.

| More on:
analyze data

Image source: Getty Images

High-quality stocks are rare, which is why the most well-known ones are often overpriced. There are simply too many investors with too much capital chasing a shrinking pool of reliable growth stocks. However, there’s always an opportunity to invest in some sectors of the market. 

In 2022, opportunities seem to be cropping up in the small-cap tech sector. Tech and growth stocks have been beaten down over the past year, but small- and mid-sized tech firms have dipped even further than the large-cap giants. That’s created some generational buy opportunities. 

Here are some of the best opportunities for your Tax-Free Savings Account (TFSA) in 2022. 

TFSA target #1

European enterprise software company Topicus.com (TSXV:TOI) is starting to look like a generational buy right now. The company’s growth model is based on acquisitions of niche software companies in Europe — where valuations were already lower. This year, valuations may have dipped further, as investors pivot away from tech and risk assets. 

Topicus stock, meanwhile, has dropped too. The price is now 26% lower than it was in November. While the price was declining, the company’s operating cash flow jumped from €121 million in the first nine months of 2020 to €133.7 million in the same period of 2021. Assuming the company is on track to generate roughly $230 million in operating cash flow, that implies a price-to-cash flow ratio of 19. 

Put simply, Topicus stock is undervalued while opportunities for growth in Europe have improved this year. This makes it a rare buy opportunity for your TFSA.

TFSA target #2

WELL Health Technologies (TSX:WELL) is another fascinating buy opportunity. This was a TFSA favourite in 2020. However, investors have moved away from telehealth stocks. That’s pushed WELL Health’s valuation to an unbelievable low. 

At the time of writing, the company expects its annual revenue run rate to exceed $450 million. Meanwhile, the stock is down 46.6% from its all-time high. WELL Health’s market cap is just 2.2 times annual revenue. In other words, the price-to-sales ratio is 2.2. 

In 2022, the WELL Health team intends to expand its footprint in the United States — the world’s largest healthcare market. Recent acquisitions have also helped the company enter new markets such as online pharmacy delivery. All these initiatives should be reflected on their balance sheet in the months ahead. 

Another signal that the company is undervalued is the recently reactivated buyback program. You read that right — a startup tech firm is financially strong enough to buy its own stock and reward long-term shareholders while it achieves double-digit growth. That alone should put WELL Health stock on your radar. 

Bottom line

Market panic and lower valuations could create some generational buying opportunities for your TFSA in 2022. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani owns Topicus.Com Inc. and WELL Health Technologies Corp. The Motley Fool owns and recommends Topicus.Com Inc.

More on Investing

Canadian Dollars bills
Dividend Stocks

3 Monthly-Paying Dividend Stocks to Boost Your Passive Income

Given their healthy cash flows and high yields, these three monthly-paying dividend stocks could boost your passive income.

Read more »

ways to boost income
Investing

Are Telus and BCE Stocks a Smart Buy for Canadian Investors?

Telus (TSX:T) and BCE (TSX:BCE) have massive dividend yields, but their shares have been quite sluggish!

Read more »

investment research
Tech Stocks

Is OpenText Stock a Buy, Sell, or Hold for 2025?

Is OpenText stock poised for a 2025 comeback? AI ambitions, a 3.8% yield, and cash flow power make it a…

Read more »

Make a choice, path to success, sign
Dividend Stocks

The TFSA Blueprint to Generate $3,695.48 in Yearly Passive Income

The blueprint to generate yearly passive income in a TFSA is to maximize the contribution limits.

Read more »

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

Emerging Canadian AI Companies With Big Potential

These tech stocks are paving the way to an AI-filled future, but still offer enough growth ahead for a strong…

Read more »

Young Boy with Jet Pack Dreams of Flying
Tech Stocks

Is Constellation Software Stock a Buy, Sell, or Hold for 2025?

CSU stock has long been a strong option for high growth, high value stocks. But are there now too many…

Read more »

rising arrow with flames
Investing

2 Riskier Stocks With High Potential for Canadian Investors in November

Risky stocks such as Well Health Technologies have the potential to provide life-changing long-term returns.

Read more »

hand stacks coins
Dividend Stocks

3 Ultra-High-Yield Dividend Stocks You Can Buy and Hold for a Decade

These three high-yield dividend stocks still have some work to do, but each are in steady areas that are only…

Read more »